Maravai Lifesciences Holdings (MRVI) Shares Outstanding (Weighted Average) (2020 - 2026)

Maravai Lifesciences Holdings' Shares Outstanding (Weighted Average) history runs 7 years deep, the most recent figure standing at $146.4 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 2.09% year-over-year to $146.4 million; the TTM figure through Mar 2026 stood at $146.4 million (up 2.09% YoY), while the FY2025 annual figure was $144.4 million, up 4.68% from the prior year.
• Shares Outstanding (Weighted Average) was $146.4 million for Q1 2026 at Maravai Lifesciences Holdings, up from $144.4 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $146.4 million in Q1 2026 to a low of $131.5 million in Q1 2022.
• Historically, Shares Outstanding (Weighted Average) has averaged $136.3 million across 5 years, with a median of $132.3 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Weighted Average) jumped 36.05% in 2022, then climbed 0.19% in 2023.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $131.5 million in 2022, then advanced by 0.28% to $131.9 million in 2023, then grew by 4.54% to $137.9 million in 2024, then rose by 4.68% to $144.4 million in 2025, then climbed by 1.43% to $146.4 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $146.4 million (Q1 2026), $144.4 million (Q4 2025), and $144.7 million (Q3 2025), per Business Quant data.